The COVID-19 treatment trials that ‘learn as they go’

Transmission electron microscope image shows SARS-CoV-2-also known as 2019-nCoV, the virus that causes COVID-19. Picture: Getty Images

Published in Pursuit, 22 April 2020

By Dr Robert Mahar, University of Melbourne, Associate Professor Steven Tong and Dr David Price, University of Melbourne and Doherty Institute of Infection and Immunity

In the event of an outbreak of an infectious disease, such as the current COVID-19 pandemic, we often know very little, yet are required to act very fast. In this article, Dr Robert Mahar and Dr David Price from the Centre for Epidemiology and Biostatistics, along with A/Prof Steven Tong from the Doherty Institute for Infection and Immunity, explain how innovative approaches to clinical trials for COVID-19 treatments can enable us to quickly hone in on the most promising treatments, saving time and potentially saving lives. Read here...